Edition:
United Kingdom

People: Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

5.53USD
25 Apr 2019
Change (% chg)

$0.02 (+0.36%)
Prev Close
$5.51
Open
$5.49
Day's High
$5.60
Day's Low
$5.41
Volume
146,340
Avg. Vol
256,705
52-wk High
$28.74
52-wk Low
$4.99

Griffin, Brian 

Mr. Brian T. Griffin is Chairman of the Board, Chief Executive Officer of the Company. As Executive Vice President and CEO for IngenioRx, a role he assumed inMarch 2018, Mr. Griffin is responsible for building the IngenioRx organization, which will begin offering a full suite of PBM solutions starting in 2020. For the three years prior, Mr. Griffin served as Executive Vice President and President of Anthem's Commercial and Specialty Business Division. He joined Anthem in 2013 as President and CEO of the company's second largest affiliated health plan, Empire BlueCross BlueShield, a role he held for two years. From 1987 toAugust 2012, Mr. Griffin served in positions of increasing responsibility with Medco Health Solutions, Inc., including as President, International and Subsidiaries of Express Scripts International Holding Company, Inc., which completed its merger with Medco Health Solutions, Inc. inApril 2012, CEO of Medco International B.V. and CEO of Medco Celesio, B.V. Prior to that, he served as Group President of Health Plans at Medco Health Solutions Inc., and was responsible for national and regional health plans, BlueCross BlueShield plans, commercial insurance carriers, consumer-driven plans and third-party administrators.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --